BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Zona Reticularis

Below is an extended Zona Reticularis patents listing. Click here to return to the Zona Reticularis main in depth entry.

Patents :

US Patent No.Title
7125549 Methods and compositions for efficient gene transfer using transcomplementary vectors
6022966 Pretargeting methods and compounds
6015897 Biotinamido-n-methylglycyl-seryl-o-succinamido-benzyl dota
5976535 Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore
5932250 Anti-cholesterolemic egg, vaccine and method for production, and use
5853765 Anti-cholesterolemic egg, vaccine and method for production, and use
5847121 Production of nitro-benzyl-dota via direct peptide cyclization
5624896 Clearing agents useful in pretargeting methods
5616690 Hexose derivatized human serum albumin clearing agents
5578287 Three-step pretargeting methods using improved biotin-active agent
5541287 Pretargeting methods and compounds
5502198 .alpha.-aryl or heteroaryl-substituted amide ester ACAT inhibitors
5420339 Alpha-aryl or heteroaryl-substituted amide ester ACAT inhibitors
5223400 Immunoassay method for determining the specificity of binding of a monoclonal antibody to an antigen
6075010 Small molecular weight ligand-hexose containing clearing agents
6096730 Phosphonated agents and their antiangiogenic and antitumorigenic use
7091248 Treatment of adrenocortical hypersecretion and tumor growth
7029857 Processes for obtaining compounds employing SNORF72 receptors
6875610 Methods and compositions for efficient gene transfer using transcomplementary vectors
6837925 Coloring pearlescent flake pigment, manufacturing method of the same and cosmetic product containing the same
6416738 Pretargeting methods and compounds
6383766 Reduced cortisol conjugates
6358710 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13
6358490 Three-step pretargeting methods and compounds
6353152 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
6217869 Pretargeting methods and compounds
6160166 Phosphonated agents and their antiangiogenic and antitumorigenic use
6147275 Corticotropin releasing factor receptor 1-deficient mice
6100058 Gap12 genes and their uses
4560557 Silicon and sulfur steroids as irreversible inhibitors of hormone biosynthesis
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional